 |
(6-[4-Deoxy-4-[(2E,4E)-tetradecadienoylglycyl] amino-L-glyceroB-L-manno-heptopyranosyl]amino-9H-purine) |
|---|---|
| Trade Name | |
| Orphan Indication | Parenteral treatment of painful, chronic, chemotherapy-induced peripheral neuropathy that is refractory to conventional analgesics |
| USA Market Approval | USA |
| USA Designation Date | 2014-02-21 00:00:00 |
| Sponsor | DARA Therapeutics, Inc.;8601 Six Forks Road, Suite 160 (Forum 1);Raleigh, North Carolina, 27615 |
